Fact CheckerSign in

NCT05206097Active, not recruiting

Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol

Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study. Protocol

Source: ClinicalTrials.gov · Last updated 10 Dec 2024

Brief summary (registry, in English)

The aim of the study is to analyze the determinants (barriers and facilitators) of the daily physical activity level in a population of patients with cystic fibrosis. A population of patients will be included in order to realize an assessment of their daily physical activity level over an entire week. A specific questionnaire, designed from 3 different questionnaires, will be associated to the physical activity evaluation and will allow to asses psycho-social and environmental factors.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
87 (actual)
First submitted
10 Jan 2022
Start date
19 Sept 2022
Primary completion date
20 Dec 2024
Lead sponsor
University Hospital, Limoges
NCT number
NCT05206097

What you commit to

  • Study type: Interventional
  • Participants enrolled: 87
  • From 19 Sept 2022 to the primary completion date, 20 Dec 2024
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • transplant patient or patient waiting for a transplant

Other

  • inability to fill in the questionnaire or to complete the planned evaluations
  • ongoing participation in another research protocol (interventional study)
  • refusal to participate in the study
  • patient under legal protection.

Who the study is looking for

  • Diagnosis of cystic fibrosis confirmed by the identification of genetic mutation and/or positive sweat test
  • regular follow-up in CF centers ;
  • age higher than 6 years old
  • stable clinical status, away from exacerbation period or antibiotic treatment.

Age in the registry: 6 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU DE BORDEAUX Hôpital des Enfants-Pellegrin - CRCM Pédiatrique
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
CHU DE BORDEAUX Hôpital Haut-Lévêque - CRCM Adulte
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
CHU DE LIMOGES Hôpital Mère Enfant - CRCM Pédiatrique
Coordinator of this site? Confirm its status
LimogesFranceUnknown status
CHU DE LIMOGES Hôpital Dupuytren 2 - CRCM Adulte
Coordinator of this site? Confirm its status
LimogesFranceUnknown status
CHU DE TOULOUSE Hôpital Larrey - CRCM Adulte
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status
CHU DE TOULOUSE Hôpital des Enfants - CRCM Pédiatrique
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.